Titan Medical (TSX:TMD) said today it inked a collaborative deal with Florida Hospital Nicholson Center to engage in a feasibility and validation study of Titan’s Sport robotic surgical system as the company seeks regulatory approval for the platform.
The Toronto-based robotic surgical system developer said it expects to commence the studies in the 4th quarter, with the studies continuing into 2018.
“We are delighted to enter into this agreement with Florida Hospital Nicholson Center for continued feasibility and validation studies for the Sport system. The Florida Hospital Nicholson Center is a world-class, state-of-the-art training and research facility with demonstrated leadership in robotic surgery innovation and training. With an accessible Orlando location, it has one of the country’s largest and most experienced medical learning and simulation incubation centers dedicated to advancing next-generation clinical knowledge. Through this strategic alliance, Titan will also benefit from access to many leading multispecialty key opinion leaders and their surgical expertise in fine-tuning the Sport system during this critical development phase. Florida Hospital Nicholson Center is one of three sites contemplated for our validation and feasibility studies. We look forward to engaging the other two sites during the current quarter, with completion of these studies in 2018,” Titan Medical rez & CEO David McNally said in a prepared statement.
“We are excited about helping Titan Medical benefit from the clinical expertise our institution offers in further refining their Sport surgical system for regulatory submission. Our brand-new, 54,000-square-foot facility is a model for open collaborations to advance practices and standards across the entire spectrum of minimally invasive, laparoscopic, robotic, telemedicine and medical simulation. It is a place where innovators come together to build upon the brilliant work of industry pioneers to achieve breakthroughs that will revolutionize the way we perform surgery. We believe that Titan’s single port surgical solution holds promise for continuing the surgical revolution,” Florida Hospital Nicholson Center chief medical officer Dr. J. Magnuson said in a press release.
Late last month, Titan Medical said it raised nearly $6 million in a public offering, with company insiders putting up another $166,000.